A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization-Reference-Cited by-同舟云学术

A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization

Published:2019-01 Issue:4 Volume:37 Page:602-611
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Bernstein David I.,Pasetti Marcela F.,Brady Rebecca^ORCID,Buskirk Amanda D.,Wahid Rezwanul,Dickey Michelle,Cohen Mitchell,Baughman Holly,El-Khorazaty Jill,Maier Nicole,Sztein Marcelo B.,Baqar Shahida,Bourgeois A. Louis

Funder

National Institute of Allergy and Infectious Diseases

National Institutes of Health

University of Maryland

PATH

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference47 articles.

1. Ad Hoc ETEC. Analysis of strategies to successfully vaccinate infants in developing countries against enterotoxigenic E. coli (ETEC) disease;Walker;Vaccine,2007

2. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity;Dickinson;Infect Immun,1995